Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Tablets – lozenges – or pills
Patent
1998-08-31
2000-08-08
Page, Thurman K.
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Tablets, lozenges, or pills
424468, 424474, 424475, 424479, 424480, A61K 924, A61K 936, A61K 920
Patent
active
060998628
ABSTRACT:
A controlled release pharmaceutical tablet containing antihyperglycemic drug and a hypoglycemic drug that does not contain an expanding or gelling polymer layer and comprising a core containing the antihyperglycemic drug and the hypoglycemic drug, a semipermeable coating membrane surrounding the core and at least one passageway in the membrane to allow the drugs to be released from the core.
REFERENCES:
patent: 3845770 (1974-11-01), Theeuwes et al.
patent: 3916899 (1975-11-01), Theeuwes et al.
patent: 3952741 (1976-04-01), Baker
patent: 3957853 (1976-05-01), Bohuon
patent: 4034758 (1977-07-01), Theeuwes
patent: 4077407 (1978-03-01), Theeuwes et al.
patent: 4080472 (1978-03-01), Bohoun
patent: 4522625 (1985-06-01), Edgren
patent: 4587117 (1986-05-01), Edgren et al.
patent: 4609374 (1986-09-01), Ayer
patent: 4612008 (1986-09-01), Wong et al.
patent: 4615698 (1986-10-01), Guittard et al.
patent: 4624847 (1986-11-01), Ayer et al.
patent: 4627850 (1986-12-01), Deters et al.
patent: 4692336 (1987-09-01), Eckenhoff et al.
patent: 4696815 (1987-09-01), Schepky et al.
patent: 4704118 (1987-11-01), Eckenhoff
patent: 4708868 (1987-11-01), Brickl et al.
patent: 4777049 (1988-10-01), Magruder et al.
patent: 4803076 (1989-02-01), Ranade
patent: 4849227 (1989-07-01), Cho
patent: 4851229 (1989-07-01), Magruder et al.
patent: 4863724 (1989-09-01), Schepky et al.
patent: 4865598 (1989-09-01), Eckenhoff
patent: 4871549 (1989-10-01), Ueda et al.
patent: 4892739 (1990-01-01), Shah et al.
patent: 4963141 (1990-10-01), Eckenhoff
patent: 5024843 (1991-06-01), Kuczynski et al.
patent: 5030452 (1991-07-01), Curatolo
patent: 5071607 (1991-12-01), Ayer et al.
patent: 5082668 (1992-01-01), Wong et al.
patent: 5091190 (1992-02-01), Kuczynski et al.
patent: 5108756 (1992-04-01), Curatolo
patent: 5110597 (1992-05-01), Wong et al.
patent: 5120548 (1992-06-01), McClelland et al.
patent: 5141752 (1992-08-01), Ayer et al.
patent: 5178867 (1993-01-01), Guittard et al.
patent: 5185158 (1993-02-01), Ayer et al.
patent: 5260275 (1993-11-01), Cooper et al.
patent: 5308348 (1994-05-01), Balaban et al.
patent: 5356913 (1994-10-01), Colca
patent: 5413572 (1995-05-01), Wong et al.
patent: 5512293 (1996-04-01), Landrau et al.
patent: 5543156 (1996-08-01), Roorda et al.
patent: 5545413 (1996-08-01), Kuczynski et al.
patent: 5591454 (1997-01-01), Kuczynski et al.
patent: 5614578 (1997-03-01), Dong et al.
patent: 5629319 (1997-05-01), Luo et al.
patent: 5631224 (1997-05-01), Efendic et al.
patent: 5650170 (1997-07-01), Wright et al.
patent: 5667804 (1997-09-01), Wong et al.
patent: 5668117 (1997-09-01), Shapiro
patent: 5674900 (1997-10-01), Ubillas et al.
patent: 5688518 (1997-11-01), Ayer et al.
patent: 5691386 (1997-11-01), Inman et al.
Diem, Drug Therapy of Type-II Diabetes: Tablets, Insulin or a Combination of These, Schweizerische Rundschau Fur Medizin Praxis, 83(2) pp68-71, Jan. 18, 1994.
Clin. Ther. 1996 May; 18 (3) : pp. 360-371.
By Briscoe TA, et al.; Dept. of Medicine Morehouse School of Medicine; Altanta, GA.
Ann. Intern Med. 1998 Feb. 1; 128 (3) pp. 165-175.
Physician's Desk Reference 52th Edition pp. 795-800; 1217-1219; and 2182-2186.
Chen Chih-Ming
Cheng Xiu Xiu
Chou Joseph
Jan Steve
ANDRX Corporation
Page Thurman K.
Seidleck Brian K.
LandOfFree
Oral dosage form for the controlled release of a biguanide and s does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Oral dosage form for the controlled release of a biguanide and s, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oral dosage form for the controlled release of a biguanide and s will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1147825